OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
83
Results
Show all
Save search
Copy query
Show results for
Unknown
(82)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Xevo G2 QTOF (Waters)
(1)
Publication Date
2018
(1)
CHEBI ID
CHEBI:138394
(1)
CHEBI:141362
(1)
CHEBI:141364
(1)
CHEBI:141366
(1)
CHEBI:16359
(1)
CHEBI:16990
(1)
CHEBI:17033
(1)
CHEBI:34485
(1)
CHEBI:43580
(1)
CHEBI:71172
(1)
CHEBI:72998
(1)
CHEBI:73858
(1)
CHEBI:74340
(1)
CHEBI:76078
(1)
CHEBI:81555
(1)
CHEBI:86255
(1)
CHEBI:88108
(1)
Metabolite Name
(9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid (HPODE)
(1)
3-indolepropionic acid (3IPA)
(1)
3-oxocholic acid -H2O (OCA)
(1)
Bilirubin (BR)
(1)
Biliverdin (BLD)
(1)
Cholic Acid (Dimer—no parent) (CA)
(1)
Enterolactone (EL)
(1)
Hexahydrohippurate (HHA)
(1)
LysoPC (LPC) (0:0/16:0)
(1)
LysoPC (LPC) (16:0/0:0)
(1)
LysoPC (LPC) (17:0/0:0)
(1)
LysoPC (LPC) (18:0/0:0)
(1)
LysoPC (LPC) (18:1(11Z)/0:0)
(1)
LysoPC (LPC) (18:2(9Z,12Z))
(1)
N-(cyclohex-1-en-1-ylcarbonyl)glycine (NCG)
(1)
N-Methylhippuric Acid (NMHA)
(1)
N-[(3alpha,5beta,12alpha)-3,12-Dihydroxy-7,24-dioxocholan-24-yl]glycine (NDGCA)
(1)
Release Date
2021
(13)
2022
(10)
2020
(10)
2023
(9)
2024
(7)
2019
(5)
2017
(5)
2025
(4)
2011
(4)
2015
(3)
2018
(2)
2016
(2)
2014
(2)
2010
(2)
2009
(2)
2026
(1)
2008
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
DIVA Metabolomics: Differentiating Vaccination Status Following Viral Challenge Using Metabolomic Profiles
This study employed metabolomic profiling technologies, to identify metabolites (small molecules) in blood which are found at different levels in vaccinated compared to non-vaccinated animals exposed to virus.
2018-07-13
|
MTBLS456
|
MetaboLights
Cite
Control of Virulence Gene Expression by the Master Regulator, CfaD, in the Prototypical Enterotoxigenic
Escherichia coli
Strain, H10407.
Not available
S-EPMC5554520
|
biostudies-literature
Cite
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial.
Not available
S-EPMC10597768
|
biostudies-literature
Cite
Outcome measures in a combined exercise rehabilitation programme for adults with COPD and chronic heart failure: A preliminary stakeholder consensus event.
Not available
S-EPMC6747864
|
biostudies-literature
Cite
Slow slip source characterized by lithological and geometric heterogeneity.
Not available
S-EPMC7096157
|
biostudies-literature
Cite
Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals.
Not available
S-EPMC6097982
|
biostudies-literature
Cite
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism.
Not available
S-EPMC7602519
|
biostudies-literature
Cite
Costs of promoting exclusive breastfeeding at community level in three sites in South Africa.
Not available
S-EPMC3888383
|
biostudies-literature
Cite
Growth effects of exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa: the cluster-randomised PROMISE EBF trial.
Not available
S-EPMC4082276
|
biostudies-literature
Cite
Malaria parasitaemia among infants and its association with breastfeeding peer counselling and vitamin A supplementation: a secondary analysis of a cluster randomized trial.
Not available
S-EPMC3131393
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
